Neuroimaging markers of hemorrhagic risk with stroke reperfusion therapy

Neurology

Volumn 79, Issue 13 SUPPL. 1, 2012, Pages

  Edgell, Randall C ^a   Vora, Nirav A ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; TISSUE PLASMINOGEN ACTIVATOR; XENON; RADIOISOTOPE;

BLOOD BRAIN BARRIER; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; HUMAN; INTRAARTERIAL REPERFUSION THERAPY; INTRAVENOUS REPERFUSION THERAPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REPERFUSION; REVIEW; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD FLOW; BRAIN INFARCTION SIZE; FIBRINOLYTIC THERAPY; PERFUSION WEIGHTED IMAGING; RANDOMIZED CONTROLLED TRIAL (TOPIC); VOXEL BASED MORPHOMETRY;

EID: 84867565634     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182695848     Document Type: Editorial

References (32)

1. The NINDS rt-PA Stroke Study Group. Intracerebral hemorrhage after intravenous tPA therapy for acute ischemic stroke. Stroke 1997;28:2109-2118.
2. Furlan A, Higashida R, Wechsler L, et al., for the PROACT Investigators. Intra-arterial prourokinase for acute ischemic stroke: the PROACT II Study. JAMA 1999;282:2003-2011.
3. Hacke W, Kaste M, Bluhmki E, et al., for the ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
4. Trouillas P, von Kummer R. Classification and pathogenesis of cerebral hemorrhages after thrombolysis in ischemic stroke. Stroke 2006;37:556-561.
5. Berger C, Fiorelli M, Steiner T, et al. Hemorrhagic transformation of ischemic brain tissue: asymptomatic or symptomatic? Stroke 2001;32:1330-1335.
6. The IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke 2004;35:904-912.
7. Smith WS, Sung G, Starkman S, et al., for the MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005;36:132-140.
8. Wahlgren N, Ahmed N, Dávalos A, et al., SITS-MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007;369:275-282.
9. Hacke W, Kaste M, Fieschi C, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: the European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
10. Patel SC, Levine SR, Tilley BC, et al., for the NINDS rt-PA Stroke Study Group. Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA 2001;286:2830-2838.
11. Barber PA, Demchuk AM, Zhang J, Buchan A, for the ASPECTS Study Group. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. Lancet 2000;355:1670-1674.
12. Demaerschalk BM, Silver B, Wong E, Merino JG, Tamayo A, Hachinski V. ASPECT scoring to estimate 1/3 middle cerebral artery territory infarction. Can J Neurol Sci 2006;33:200-204.
13. Kent DM, Hill MD, Ruthazer R, et al. "Clinical-CT mismatch" and the response to systemic thrombolytic therapy in acute ischemic stroke. Stroke 2005;36:1695-1699.
14. Hill MD, Rowley HA, Adler F, et al., for the PROACT-II Investigators. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 2003;34:1925-1931.
15. Hill MD, Demchuk AM, Tomsick TA, Palesch YY, Broderick JP. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am J Neuroradiol 2006;27:1612-1616.
16. Latchaw RE, Yonas H, Hunter GJ, et al. Guidelines and recommendations of perfusion imaging in cerebral ischemia: a scientific statement for healthcare professionals by the writing group on perfusion imaging, from the Council on Cardiovascular Radiology of the American Heart Association. Stroke 2003;34:1084-1104.
17. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intra-arterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke 1994;25:298-303.
18. Gupta R, Yonas H, Gebel J, et al. Reduced pretreatment ipsilateral middle cerebral artery cerebral blood flow is predictive of symptomatic hemorrhage post-intra-arterial thrombolysis in patients with middle cerebral artery occlusion. Stroke 2006;37:2526-2530.
19. Bhatt A, Vora NA, Thomas AJ, et al. Lower pre-treatment cerebral blood volume increases hemorrhagic risks after intra-arterial revascularization in acute stroke. Neurosurgery 2008;63:874-879.
20. Kidwell CS, Chalela JA, Saver JL, et al. Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 2004;292:1823-1830.
21. Kakuda W, Thijs VN, Lansberg MG, et al., DEFUSE Investigators. Clinical importance of microbleeds in patients receiving IV thrombolysis. Neurology 2005;65:1175-1178.
22. Fiehler J, Albers GW, Boulanger JM, et al., for the MR Stroke Group. Bleeding risk analysis in stroke imaging before thrombolysis. Stroke 2007;38:2738-2744.
23. Derex L, Nighoghossian N. Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update. J Neurol Neurosurg Psychiatry 2008;79:1093-1099.
24. del Zoppo GJ, von Kummer R, Hamann GF. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. JNNP 1998;65:1-9.
25. Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 2004;35(suppl I):2659-2661.
26. Tong DC, Adami A, Moseley ME, Marks MP. Relationship between apparent diffusion coefficient and subsequent hemorrhagic transformation following acute ischemic stroke. Stroke 2000;31:2378-2384.
27. Selim M, Fink JN, Kumar S, et al. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume. Stroke 2002;33:2047-2052.
28. Singer OC, Humpich MC, Fiehler J, et al., for the MR Stroke Study Group Investigators. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion-weighted magnetic resonance imaging. Ann Neurol 2008;63:52-60.
29. Lansberg MG, Thijs VN, Bammer R, et al., DEFUSE Investigators. Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke. Stroke 2007;38:2275-2278.
30. Albers GW, Thijs VN, Wechsler L, et al., for the DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the Diffusion and Perfusion Imaging Evaluation For Understanding Stroke Evolution (DEFUSE) study. Ann Neurol 2006;60:508-517.
31. Leiva-Salinas C, Wintermark M. The future of stroke imaging: what we need and how to get to it. Stroke 2010;41:S152-S153.
32. Schellinger PD, Bryan RN, Caplan LR, et al; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Evidence-based guideline: the role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010;75:177-185.